R. Kirkie Maswoswe

• Markforged in its pending $115 million take-private sale to Nano Dimension
• Pathology Watch in its $130 million sale to Sonic Healthcare
• Berkshire Grey in its $375 million take-private sale to SoftBank
• FactSet in its $1.9 billion carve-out acquisition of CUSIP Global Services from S&P Global*
• Genesys in its:
  • Carve-out acquisition of the Bold360 business from LogMeIn*
  • Acquisitions of Exceed.ai and Pointillist*
• Permira in its significant investments in CommentSold, Click&Boat, and Boats Group*
• LifeLock in its $2.3 billion sale to Symantec*
• Trader Corporation in its $1.6 billion sale to Thoma Bravo*
• Dyn in its sale to Oracle*
• Thomson Reuters in its acquisition of Integration Point*
• Genpact in its $550 million acquisition of Headstrong*

*Denotes experience prior to joining Goodwin

• Novo Holdings in its pending $16.5 billion take-private acquisition of Catalent
• ImmuNext in its $525 million sale to Royalty Pharma
• Novo Holdings in its $462 million take-private acquisition of Paratek Pharmaceuticals with Gurnet Point Capital
• GreenLight Biosciences in its $45.5 million take-private sale to a consortium led by Fall Line
• LumiraDx in its $3 billion de-SPAC merger with CA Healthcare*
• Goldman Sachs as a member of the buyer consortium in its $1.6 billion acquisition of New Frontier Health*
• ImmunityBio in its $3.6 billion merger with NantKwest*
• Synageva BioPharma in its $8.4 billion sale to Alexion Pharmaceuticals*
• Pfizer in its $17 billion acquisition of Hospira*
• Cubist Pharmaceutical in its $9.5 billion sale to Merck*
• Pfizer in its €115 million acquisition of two meningitis vaccines from GlaxoSmithKline*
• Mylan in its acquisition of Synerx Pharma*

*Denotes experience prior to joining Goodwin

• Board of Directors of Home Partners of America in the $6 billion sale of Homes Partners of America to Blackstone*
• Extended Stay in its $6.1 billion sale to Blackstone and Starwood*

*Denotes experience prior to joining Goodwin

• Morgan Stanley as financial advisor to Envestnet in its pending $4.5 billion sale to Bain Capital
• Qatalyst Partners as financial advisor to Alteryx in its $4.4 billion sale to Clearlake Capital Group and Insight Partners
• J.P. Morgan as financial advisor to Flexion Therapeutics in its $630 million sale to Pacira Biosciences*
• Evercore as financial advisor to Canadian Pacific in its $29 billion merger agreement with Kansas City Southern*
• Goldman Sachs as financial advisor to Penn National in its $2 billion acquisition of theScore*
• Lazard as financial advisor to Versum Materials in its $5.8 billion merger with Merck*
• Morgan Stanley as financial advisor to El Paso in its $38 billion merger with Kinder Morgan*

*Denotes experience prior to joining Goodwin

• WHP Global in its transformative strategic transaction with Express and acquisition of Bonobos
• Mondelez in its $30 billion spin-off of Kraft Foods*
• DreamWorks Animation in the formation of Oriental DreamWorks, a China-focused media joint venture, with China Media Capital and Shanghai Media Group*
• Aramex in its $265 million acquisition of MyUS*
• Special Committee of Market Basket in the $1.5 billion shareholder buyout of Market Basket*
• Marquee Brands in its acquisition of Ben Sherman and related IP assets from Oxford Industries*
• BAE Systems in its $114 million sale of Safariland to Kanders*
• Stanley in its $1.1 billion sale to CGI Group*

*Denotes experience prior to joining Goodwin